The Director General of Biosintez PJSC was awarded with a certificate of honor

Biosintez (Sun Pharma manufacturing site) has launched production of the Dioxymet® BSZ medicinal product (INN:  hydroxymethylquinoxaline dioxide) in the form of a topical ointment with a dosage of 5%.

Today, as part of the Chemist's Day celebration, the Company held an award ceremony for its employees.

On March 23, Penza State University (PSU) hosted a large-scale meeting of our company with students of specialties of the Medical, Pedagogical and Polytechnic Institutes as part of the Career Day at PJSC “Biosintez”.

The drug contains two ingredients: glibenclamide and metformin. * Metformin and glibenclamide differ in mechanisms of action and complement each other's hypoglycemic activity.

Another OTC drug of the NSAID group - Brustel was added to the Sun Pharma's portfolio in Russia.
The drug composition includes ketoprofen and is released in the form of a topical gel at a maximum therapeutic dosage of 5%.

Dear friends! Happy New Year 2022!

Using its own substance, Biosintez is planning to increase the production of a sodium nucleinate-based immunomodulator.

The drug contains two ingredients: glibenclamide and metformin. * Metformin and glibenclamide differ in mechanisms of action and complement each other's hypoglycemic activity.